Difference between revisions of "Steroid conversions"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm")
m (Text replacement - "3 PubMed]" to "3/ PubMed]")
 
(3 intermediate revisions by 2 users not shown)
Line 45: Line 45:
  
 
==References==
 
==References==
# Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. [https://www.ncbi.nlm.nih.gov/pubmed/888843 PubMed]
+
# Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. [https://pubmed.ncbi.nlm.nih.gov/888843/ PubMed]
 +
 
 +
[[Category:General reference pages]]
 +
[[Category:Clinical pharmacology]]

Latest revision as of 23:27, 26 April 2023

Steroid Equivalent (glucocorticoid) dose (mg) Half-life (hours), biologic Relative anti-inflammatory (glucocorticoid) potency Relative mineralocorticoid (Na+ retaining) potency
Cortisone 25 8-12 0.8 0.8
Hydrocortisone (Cortef) 20 8-12 1 1
Prednisone (Sterapred) 5 18-36 4 0.8
Prednisolone (Millipred) 5 18-36 4 0.8
Methylprednisolone (Solumedrol) 4 18-36 5 0.5
Dexamethasone (Decadron) 0.75 36-54 25 0

References

  1. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. PubMed